Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid Corporation : Rite Aid to Release Fourth Quarter Results on April 11

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/25/2013 | 01:25pm CET

Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2013 Fourth Quarter, which ended March 1, 2013, on Thursday, April 11, 2013. The company will hold an analyst call at 8:30 a.m. Eastern Daylight Time (5:30 a.m. Pacific Time) with remarks by Rite Aid's management team. The call will be broadcast via the Internet and can be accessed through the websites www.riteaid.com and www.StreetEvents.com.

A playback of the call will be available on the Internet at www.riteaid.com and www.StreetEvents.com starting at 12 p.m. Eastern Daylight Time Thursday, April 11. The playback will be available on both sites until the company's next conference call.

A playback of the call will also be available by telephone beginning at 12 p.m. Eastern Daylight Time on April 11, 2013 and ending at 11:59 p.m. Eastern Daylight Time on April 13, 2013. The playback number is (855) 859-2056 from within the U.S. and Canada or (404) 537-3406 from outside the U.S. and Canada with the eight-digit reservation number 24861186.

Rite Aid is one of the nation's leading drugstore chains with more than 4,600 stores in 31 states and the District of Columbia with fiscal 2012 annual revenues of $26.1 billion. Information about Rite Aid, including corporate background and press releases, is available through Rite Aid's website at www.riteaid.com.

Rite Aid Corporation
INVESTORS:
Matt Schroeder, 717-214-8867
or
MEDIA:
Susan Henderson, 717-730-7766


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
12/06 Moberg Pharma considers an acquisition of a brand from Prestige Brands and ev..
12/06 RITE AID : Siniawa plans retail center in W-B
12/06 RITE AID : Developer looking to attract tenants for proposed W-B center
12/05 RITE AID : Supports National Influenza Vaccination Week with Discounted Flu Shot..
12/05 RITE AID : Police investigate 'suspicious' death
12/01 MARCUS & MILLICHAP : Rite Aid in Midlothian sells for $3.4 million
12/01 RITE AID : McQueary unable to get a job at Rite Aid, and other key points by the..
11/29 RITE AID : Police arrest man after failed "bomb" robbery
11/25 RITE AID : Hackensack Meridian opening Rite Aid clinics
11/22 RITE AID : Customers Can Now Use American Express® Membership Rewards® Points fo..
More news
Sector news : Retail - Drugs without Grocery
11/16DJTarget Draws Back Shoppers
11/16DJWALGREENS BOOTS ALLIANCE : Claims Theranos Voided 11.3% of Test Reports
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/09DJWALGREENS BOOTS ALLIANCE : Walgreen Sues Theranos, Seeking to Recover $140 Milli..
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
12/07 Rite Aid seen as interesting arb pick
12/07 What Is The Top Arb Bet For 2017?
11/29 No Stopping The Rally? Cramer's Mad Money (11/28/16)
11/25 Black Friday (Arb) Bargains
11/22 The Superior Investment For Next Decade - Walgreens Boots Alliance Or CVS?
Advertisement
Financials ($)
Sales 2017 32 800 M
EBIT 2017 676 M
Net income 2017 126 M
Debt 2017 6 848 M
Yield 2017 -
P/E ratio 2017 64,24
P/E ratio 2018 43,42
EV / Sales 2017 0,47x
EV / Sales 2018 0,45x
Capitalization 8 543 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,58 $
Spread / Average Target 5,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION3.57%8 543
RAIA DROGASIL SA76.34%6 030
AIN HOLDINGS INC39.02%2 212
ORIOLA KD OYJ1.16%833
AUSTRALIAN PHARMACEUTI..-3.11%681
ADCOCK INGRAM HOLDINGS..-5.57%598
More Results